We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
+20.63%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
AUM
$473M
AUM Growth
+$23.4M
Cap. Flow
-$55.5M
Cap. Flow %
-11.74%
Top 10 Hldgs %
57.44%
Holding
167
New
23
Increased
40
Reduced
39
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 41.76%
2 Industrials 9.79%
3 Consumer Discretionary 6.65%
4 Financials 3.72%
5 Healthcare 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIS icon
1
Fidelity National Information Services
FIS
$21.5B
$112M 23.68%
835,615
-433,405
-34% -$56.9M
BKI
2
DELISTED
Black Knight, Inc. Common Stock
BKI
$42.6M 9%
586,588
-441
-0.1% -$31.3K
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$24.9M 5.26%
79,972
-9,608
-11% -$2.81M
MAN icon
4
ManpowerGroup
MAN
$2.39B
$18.4M 3.88%
267,337
ZWS icon
5
Zurn Elkay Water Solutions
ZWS
$8.07B
$17.4M 3.67%
1,237,007
+230,338
+23% +$3.02M
IVV icon
6
iShares Core S&P 500 ETF
IVV
$876B
$12.6M 2.66%
40,712
-1,294
-3% -$380K
CNNE icon
7
Cannae Holdings
CNNE
$647M
$12.3M 2.59%
298,435
+133,333
+81% +$4.56M
GPI icon
8
Group 1 Automotive
GPI
$3.94B
$11.7M 2.47%
177,399
QQQ icon
9
Invesco QQQ Trust
QQQ
$455B
$10.4M 2.19%
41,858
+2,022
+5% +$453K
VYX icon
10
NCR Voyix
VYX
$1.06B
$9.55M 2.02%
898,749
-5,063
-0.6% -$58K
XBI icon
11
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$9.31M 1.97%
83,180
-2,310
-3% -$228K
XLF icon
12
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$8.74M 1.85%
377,729
+40,381
+12% +$917K
CDW icon
13
CDW
CDW
$17.1B
$8.48M 1.79%
73,030
+10,062
+16% +$1.09M
FNF icon
14
Fidelity National Financial
FNF
$13.9B
$8M 1.69%
271,212
+50,201
+23% +$1.38M
AAPL icon
15
Apple
AAPL
$4.89T
$7.51M 1.59%
82,328
-10,452
-11% -$810K
IJH icon
16
iShares Core S&P Mid-Cap ETF
IJH
$123B
$6.91M 1.46%
194,315
-17,230
-8% -$572K
IEFA icon
17
iShares Core MSCI EAFE ETF
IEFA
$186B
$6.67M 1.41%
116,711
+7,797
+7% +$423K
IBB icon
18
iShares Biotechnology ETF
IBB
$9.31B
$5.65M 1.19%
41,341
-545
-1% -$69.5K
IJR icon
19
iShares Core S&P Small-Cap ETF
IJR
$109B
$5.29M 1.12%
77,388
-10,664
-12% -$673K
MMM icon
20
3M
MMM
$89B
$5.27M 1.11%
40,377
+263
+0.7% +$33.1K
IWP icon
21
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$5.18M 1.1%
65,586
-6,278
-9% -$455K
IWO icon
22
iShares Russell 2000 Growth ETF
IWO
$14.5B
$4.61M 0.98%
22,301
-19,676
-47% -$3.68M
IWF icon
23
iShares Russell 1000 Growth ETF
IWF
$122B
$4.57M 0.97%
95,304
-1,496
-2% -$65.9K
CQQQ icon
24
Invesco China Technology ETF
CQQQ
$2.95B
$4.55M 0.96%
71,740
EFA icon
25
iShares MSCI EAFE ETF
EFA
$76.4B
$4.41M 0.93%
72,373
+412
+0.6% +$23.8K

Similar funds

Crescent Grove Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Crescent Grove Advisors held 167 positions worth $473M, up 5.2% from $450M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Crescent Grove Advisors withdrew a net $55.5M in Q2 2020, closing 15 positions and reducing 39 holdings. Its most notable exit was FGL Holdings Ordinary Shares, an estimated $5.51M position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 50% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Crescent Grove Advisors opened a new position in iShares Global Healthcare ETF worth $1.1M.

  • Crescent Grove Advisors's largest Q2 2020 buy was iShares Global Healthcare ETF: 16,000 shares worth $1.1M.
  • Crescent Grove Advisors added most to Cannae Holdings in Q2 2020, an estimated $4.56M increase.
  • Crescent Grove Advisors's biggest Q2 2020 reduction was Fidelity National Information Services, cutting an estimated $56.9M.
  • Crescent Grove Advisors fully exited FGL Holdings Ordinary Shares in Q2 2020, selling an estimated $5.51M.
  • Crescent Grove Advisors's ten largest holdings make up 57% of its $473M portfolio in Q2 2020.
  • Crescent Grove Advisors opened 23 new positions and closed 15 in Q2 2020.
  • Crescent Grove Advisors's portfolio value rose 5.2% quarter-over-quarter to $473M.

Based on Crescent Grove Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.